TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A post hoc analysis of a randomized trial found that older adults assigned to eat walnuts daily had about 6% higher total IgG after two years than participants told to avoid walnuts. The study did not find significant effects on several other immune measures, and it cannot show that the IgG difference improves health or prevents heart disease.
A two-year analysis of the Walnuts and Healthy Aging trial found that older adults assigned to eat walnuts daily had about 6% higher total IgG than those assigned to a walnut-free diet. The finding concerns an immune-system biomarker, not a demonstrated health benefit: researchers said the clinical implications remain uncertain.
The analysis, published in JACC Advances, examined blood samples from 474 participants in the randomized WAHA trial: 240 in the walnut group and 234 in the control group. Participants were cognitively healthy adults aged 63 to 79 living in the United States or Spain. The researchers compared measurements taken at the start of the trial and after two years.
Participants assigned to the intervention were asked to eat 30 to 60 grams of walnuts a day, amounting to about 15% of daily energy intake, while the control group followed a diet that excluded walnuts. The original trial focused on cognitive function and retinal integrity; this immune-biomarker analysis was conducted afterward. Researchers measured total immunoglobulin G (IgG) and immunoglobulin M (IgM), as well as antibodies directed at MDA-LDL, an altered form of LDL associated with oxidative processes.
The adjusted results showed higher total IgG in the walnut group across the two study centers combined. The difference was 11% among U.S. participants, but researchers found no statistically significant intervention effect in Spain. Walnut consumption was not associated with significant differences in total IgM, MDA-LDL concentrations, or either class of MDA-LDL-specific antibodies. Several measures, including total IgG and IgM, fell over time in both groups.
What Higher IgG Can—and Cannot—Show
IgG is an antibody, one of the proteins involved in the body’s humoral immune response. A higher total concentration is a change in a blood measure; by itself, it does not establish that someone has stronger protection against infection, less inflammation, or a lower risk of cardiovascular disease. The study did not test whether participants experienced fewer illnesses or heart attacks as a result of the difference.
The question matters because atherosclerosis involves plaque formation and chronic inflammation, and immune responses may play a role in how the disease develops. Earlier research has linked some antibody measures with cardiovascular outcomes, but those findings do not prove that raising total IgG through diet changes a person’s risk. This analysis adds a possible dietary signal for researchers to investigate, not a basis for recommending walnuts as an immune treatment or heart-disease prevention strategy.
The modest overall difference and the variation between the U.S. and Spanish results also argue for restraint. A biomarker can help generate hypotheses, but clinical outcomes and replication in further research are needed to establish whether a change is meaningful to health.
Products Worth Considering
Garmin Forerunner 55 GPS Running Smartwatch, Black
Garmin Forerunner 570 GPS Running Smartwatch, 47mm, Aluminum, Black
Coway Mighty AP-1512HH(W) Air Purifier, White
As an affiliate, we earn on qualifying purchases.
How the WAHA Trial Was Analyzed
The WAHA trial enrolled 708 adults in Spain and the United States between May 2012 and May 2014. Participants were randomly assigned to a walnut-based or walnut-excluding diet for two years. People who already ate more than two servings of tree nuts per week were excluded, as were some people using supplements such as fish oil or flaxseed oil.
For the later immune analysis, blood samples were available from 474 participants. The team used laboratory assays to measure the immune markers and statistical models adjusted for factors including age, sex, smoking status, study center, cholesterol, body mass index, hypertension and diabetes. In Spanish participants, red blood cell alpha-linolenic acid levels rose substantially in the walnut group relative to the control group, a measure the researchers used to support dietary adherence.
The analysis found that baseline antibody concentrations differed between the two centers: U.S. participants had lower total IgG and IgM than Spanish participants. The study also reported differing participant characteristics across centers. Those differences provide relevant context for interpreting why the IgG result appeared in the combined analysis and U.S. subgroup but was not statistically significant in Spain.
“The clinical implications remain uncertain.”
— The study authors, as reported by News-Medical
Limits of the IgG Finding
The results do not establish why IgG was higher, whether the difference has a beneficial or harmful effect, or whether it persists beyond the two-year trial. The absence of a statistically significant effect in Spain also leaves open whether the overall association applies consistently across populations. The report does not establish that the U.S. subgroup result reflects a true difference between countries.
This was a post hoc analysis, and immune biomarkers were measured in a subset of the original 708 participants. The analysis was not designed to determine whether walnut consumption prevents infections, changes immune-related illness, or reduces cardiovascular events. Researchers also found no significant walnut-related changes in several other measured markers, including total IgM and MDA-LDL-specific antibodies. Further studies would be needed to test whether the IgG finding is reproducible and clinically relevant.
Evidence Needed Beyond Biomarkers
The report does not identify a scheduled follow-up study or a next milestone. The findings may inform future research, but confirming their meaning would require additional studies that examine the IgG result in other groups and assess health outcomes, not just antibody concentrations. Until then, the evidence supports a limited conclusion: a walnut diet was associated with a difference in total IgG in this trial, while any effect on health remains unproven.
Key Questions
What is IgG?
Immunoglobulin G (IgG) is a type of antibody in the blood. The study measured total IgG, which is a broad immune biomarker; it did not show that a higher level necessarily means better protection or improved health.
How much higher was IgG among walnut eaters?
After two years, adjusted total IgG was about 6% higher in the walnut group than the control group across both centers. The U.S. subgroup difference was 11%, while no statistically significant effect was detected in Spain.
Did the study show that walnuts prevent heart disease?
No. The analysis measured immune markers and did not establish that eating walnuts reduced heart attacks, atherosclerosis, or other cardiovascular outcomes.
Did walnuts change every immune marker measured?
No. Researchers found no significant intervention effect on total IgM, MDA-LDL concentrations, or MDA-LDL-specific IgM and IgG antibodies. Several measures declined over time in both groups.
Does the finding mean people should eat walnuts to raise IgG?
The study does not establish that raising IgG is beneficial or recommend walnuts as an immune treatment. It reports an association in a specific trial population, and the health meaning remains uncertain.
Source: news-medical.net
